Publicacións nas que colabora con Juan Jesús Gómez-Reino Carnota (73)
2019
-
Evaluation of 12 GWAS-drawn SNPs as biomarkers of rheumatoid arthritis response to TNF inhibitors. A potential SNP association with response to etanercept
PLoS ONE, Vol. 14, Núm. 2
-
Specific Association of HLA–DRB1*03 With Anti–Carbamylated Protein Antibodies in Patients With Rheumatoid Arthritis
Arthritis and Rheumatology, Vol. 71, Núm. 3, pp. 331-339
2018
-
Replication study of polymorphisms associated with response to methotrexate in patients with rheumatoid arthritis
Scientific Reports, Vol. 8, Núm. 1
-
Validation study of genetic biomarkers of response to TNF inhibitors in rheumatoid arthritis
PLoS ONE, Vol. 13, Núm. 5
2017
2016
-
Anti-carbamylated protein antibodies as a reproducible independent type of rheumatoid arthritis autoantibodies
PLoS ONE, Vol. 11, Núm. 8
-
Independent candidate serum protein biomarkers of response to adalimumab and to infliximab in rheumatoid arthritis: An exploratory study
PLoS ONE, Vol. 11, Núm. 4
-
Replication of PTPRC as genetic biomarker of response to TNF inhibitors in patients with rheumatoid arthritis
Pharmacogenomics Journal, Vol. 16, Núm. 2, pp. 137-140
-
Specific premature epigenetic aging of cartilage in osteoarthritis
Aging, Vol. 8, Núm. 9, pp. 2222-2231
2015
-
Assessment of global DNA methylation in peripheral blood cell subpopulations of early rheumatoid arthritis before and after methotrexate
Arthritis Research and Therapy, Vol. 17, Núm. 1
-
Effect of lysophosphatidic acid receptor inhibition on bone changes in ovariectomized mice
Journal of Bone and Mineral Metabolism, Vol. 33, Núm. 4, pp. 383-391
-
FCGR polymorphisms in the treatment of rheumatoid arthritis with Fc-containing TNF inhibitors
Pharmacogenomics, Vol. 16, Núm. 4, pp. 333-345
-
Rheumatoid arthritis response to treatment across IgG1 allotype - anti-TNF incompatibility: A case-only study
Arthritis Research and Therapy, Vol. 17, Núm. 1
2014
-
Association of FCGR2A with the response to infliximab treatment of patients with rheumatoid arthritis
Pharmacogenetics and Genomics, Vol. 24, Núm. 5, pp. 238-245
-
Lack of replication of higher genetic risk load in men than in women with systemic lupus erythematosus
Arthritis Research and Therapy, Vol. 16, Núm. 3
-
Lack of replication of interactions between polymorphisms in rheumatoid arthritis susceptibility: Case-control study
Arthritis Research and Therapy, Vol. 16, Núm. 1
-
Lack of validation of genetic variants associated with anti-tumor necrosis factor therapy response in rheumatoid arthritis: A genome-wide association study replication and meta-analysis
Arthritis Research and Therapy, Vol. 16, Núm. 2
-
Lysophosphatidic acid receptor inhibition as a new multipronged treatment for rheumatoid arthritis
Annals of the Rheumatic Diseases, Vol. 73, Núm. 1, pp. 298-305
-
Non-HLA genes PTPN22, CDK6 and PADI4 are associated with specific autoantibodies in HLA-defined subgroups of rheumatoid arthritis
Arthritis Research and Therapy, Vol. 16, Núm. 4
2013
-
Identification of three new cis-regulatory IRF5 polymorphisms: In vitro studies
Arthritis Research and Therapy, Vol. 15, Núm. 4